Pharmaxis

Pharmaxis is an Australian pharmaceutical research company specializing in the development and commercialization of therapies for respiratory and immune diseases. Their product portfolio includes Aridol, used to detect bronchial hyperresponsiveness, and Bronchitol, approved for marketing in Australia and Europe. The company is headquartered in Frenchs Forest, New South Wales, Australia, with additional offices in Dublin, Ireland, and London, United Kingdom.

• Biotech